Spark Therapeutics (NASDAQ: ONCE) and Pfizer Inc. (NYSE: PFE) today announced they have entered into an amendment to their license ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE